Clinical Trial Radar | Bavarian Nordic

Trial Radar AI Trial Candidate or Patient Patient Caregiver Healthcare Pro Biotech Pro Biotech Investor Researcher Other
	Let's discuss and explore clinical trials with Bavarian Nordic as a lead sponsor or collaborator. I can help you find nearby clinical trials and understand health conditions and treatments.

Let's discuss and explore clinical trials with Bavarian Nordic as a lead sponsor or collaborator.

I can help you find nearby clinical trials and understand health conditions and treatments.

Study Title	Status
An Efficacy, Safety, and Immunogenicity Study of CHIKV VLP Vaccine for the Prevention of Chikungunya Disease in Adolescents and Adults NCT07467707	Not yet recruiting
Comparability Trial of the MVA-BN Vaccine Manufactured in Different Production Cells NCT07199569	Recruiting
A Safety and Immunogenicity Study of CHIKV VLP Vaccine in Children. NCT07003984	Recruiting
A Phase 2 Trial in Healthy Adult Participants of the Recombinant MVA-BN-WEV Vaccine NCT06899802	Active, not recruiting
Phase 3 Maternal Safety & Immunogenicity Trial of MVA-BN® in DRC (PregInPoxVac) NCT06844500	Active, not recruiting
Phase 3 Infant Safety & Immunogenicity Trial of MVA-BN® in DRC (PregInPoxVac) NCT06844487	Recruiting
Long-term Follow-up Study to Evaluate Safety and Immunogenicity of PXVX0317 Single or Booster Vaccination NCT06007183	Active, not recruiting
Safety and Immunogenicity of CHIKV VLP Vaccine PXVX0317 in Adults ≥65 Years NCT05349617	CompletedResults Posted
ABNCoV2 Vaccine in Adult Subjects Previously Vaccinated for SARS-CoV-2 NCT05329220	CompletedResults Posted
MVA-BN-RSV Vaccine Trial NCT05238025	TerminatedResults Posted
ABNCoV2 Vaccine in SARS-CoV-2 (COVID-19) Seronegative and Seropositive Adult Subjects NCT05077267	CompletedResults Posted
A Phase 3 Trial of the VLP-Based Chikungunya Vaccine PXVX0317 (CHIKV VLP Vaccine) NCT05072080	CompletedResults Posted
A Study to Assess the Safety and Immunogenicity of PXVX0317 Chikungunya Virus Virus-Like Particle Vaccine (CHIKV VLP) NCT05065983	CompletedResults Posted
Phase 2a Study of MVA-BN-RSV Vaccination and RSV Challenge in Healthy Adults NCT04752644	Completed
TAEK-VAC-HerBy Vaccine for Brachyury and HER2 Expressing Cancer NCT04246671	Completed
A Phase 1 Open Label Trial of Intravenous Administration of MVA-BN-Brachyury Vaccine in Patients With Advanced Cancer NCT04134312	Completed
Vaccination Trial of a Recombinant MVA-BN-WEV Vaccine in Healthy Adult Subjects NCT04131595	Completed
Phase 2 Open-label Study of Alum-adjuvanted Chikungunya Virus-like Particle Vaccine (PXVX0317) (WRAIR) NCT03992872	CompletedResults Posted
Cohort Study of Healthcare Workers Receiving Imvanex® NCT03745131	Completed
Freeze-Dried MVA-BN® Lot Consistency Smallpox Trial NCT03699124	CompletedResults Posted
CV301 Combined With PD-1/L1 Blockade in Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer NCT03628716	CompletedResults Posted
Safety, Reactogenicity and Immunogenicity of Adenovirus Serotype 26 (Ad26)- and Modified Vaccinia Ankara (MVA)-Vectored Vaccine Components in Otherwise Healthy Women With HPV16 or HPV18 Infection of the Cervix NCT03610581	TerminatedResults Posted
BN Brachyury and Radiation in Chordoma NCT03595228	CompletedResults Posted
A Trial of Perioperative CV301 Vaccination in Combination With Nivolumab and Systemic Chemotherapy for Metastatic CRC NCT03547999	TerminatedResults Posted
Neoantigen DNA Vaccine in Combination With Nivolumab/Ipilimumab and PROSTVAC in Metastatic Hormone-Sensitive Prostate Cancer NCT03532217	Completed
Trial of a Chikungunya Vaccine, PXVX0317 CHIKV-VLP, in Healthy Adults NCT03483961	CompletedResults Posted
Special Access Program IMVAMUNE® NCT03472014	CompletedResults Posted
Durvalumab Plus CV301 With Maintenance Chemotherapy in Metastatic Colorectal or Pancreatic Adenocarcinoma NCT03376659	TerminatedResults Posted
Safety and Tolerability Trial (MVA-BN-Brachyury/FPV-Brachyury) NCT03349983	Completed
VAXCHORA Pediatric Study to Assess Safety and Immunogenicity NCT03220737	CompletedResults Posted
JYNNEOS Smallpox Vaccine in Adult Healthcare Personnel at Risk for Mpox in the Democratic Republic of the Congo NCT02977715	Active, not recruiting
RSV-MVA-BN Vaccine Phase II Trial in ≥ 55 Year Old Adults NCT02873286	CompletedResults Posted
RSV-MVA-BN Vaccine Phase I Trial, Intranasal Application in Adults. NCT02864628	Withdrawn
A Trial of CV301 in Combination With Anti-PD-1 Therapy in Subjects With Non-Small Cell Lung Cancer NCT02840994	Completed
Adjuvant PROSTVAC-V/F in Subjects at High Risk for Relapse After Radical Prostatectomy NCT02772562	TerminatedResults Posted
Long-term Safety Follow-up of Participants Exposed to the Candidate Ebola Vaccines Ad26.ZEBOV and/or MVA-BN-Filo NCT02661464	TerminatedResults Posted
Neoadjuvant PROSTVAC-VF With or Without Ipilimumab for Prostate Cancer NCT02506114	TerminatedResults Posted
Trial to Evaluate the Safety, Tolerability and Immunogenicity of the Recombinant MVA BN® RSV Vaccine NCT02419391	Completed
Phase 4 Study To Assess The Safety Of Vivotif At Different Release Titers Among Travelers NCT02391909	Completed
A Study of Live Oral Cholera Vaccine, PXVX200 in Healthy Older Adults NCT02100631	CompletedResults Posted
A Phase 3 Lot to Lot Consistency Study of Live Oral Cholera Vaccine, PXVX0200 in Healthy Adults NCT02094586	CompletedResults Posted
Randomized, Open-label Phase II Trial to Assess the Safety and Immunogenicity of MVA-BN Smallpox Vaccine in Immunocompromised Subjects With HIV Infection NCT02038881	CompletedResults Posted
A Non-inferiority Trial to Compare MVA-BN® Smallpox Vaccine to ACAM2000® NCT01913353	CompletedResults Posted
Safety and Efficacy Challenge Study of Live Oral Cholera Vaccine Candidate,PXVX0200, to Prevent Cholera NCT01895855	CompletedResults Posted
A Phase II Trial to Compare a Liquid-frozen and a Freeze-dried Formulation of IMVAMUNE (MVA-BN®) Smallpox Vaccine in Vaccinia-naïve Healthy Subjects NCT01668537	CompletedResults Posted
Safety and Immunogenicity of the Live Oral Cholera Vaccine Candidate PXVX0200 NCT01585181	Completed
A Randomized, Double-blind, Phase 3 Efficacy Trial of PROSTVAC-V/F +/- GM-CSF in Men With Asymptomatic or Minimally Symptomatic Metastatic Castrate-Resistant Prostate Cancer (Prospect) NCT01322490	CompletedResults Posted
A Safety and Immunology Study of a Modified Vaccinia Vaccine for HER-2(+) Breast Cancer After Adjuvant Therapy NCT01152398	Completed

Phase

Type

Study Type

Age Group

Biological Sex

Placebo

Phase

Type

Study Type

Age Group

Biological Sex